Before he ran for Senate, Sam Brown profited from his role as a middle-man in the pharmaceutical industry
Brown ran a company that served as a pharmacy benefit manager (PBM) and has been a vocal defender of PBMs, which have been shown to raise drug costs for patients. He also opposed Democratic measures to lower prescription drugs costs and to allow Medicare to negotiate for lower drug prices.